Fielmann AG (FLMNY)

Fielmann AG (FLMNY) Healthcare & Pipeline Overview

Fielmann AG stands as a leading retailer in the optical and audiological sectors, offering a comprehensive range of eyewear and hearing aids through an extensive network of stores and online platforms, positioning itself as a trusted brand in the European market.

What Is the Investment Thesis for FLMNY?

Fielmann AG presents a solid investment thesis driven by its robust market position in the optical and audiological sectors, evidenced by a market capitalization of $4.25B and a P/E ratio of 17.1. The company boasts a profit margin of 8.4% and a gross margin of 26.9%, indicating operational efficiency. Key growth catalysts include the expansion of its retail footprint and the increasing demand for hearing aids, driven by an aging population in Europe. With 693 retail locations and a strong online presence, Fielmann is well-positioned to capture market share in the growing eyewear and hearing aid markets. However, potential risks include fluctuations in consumer spending and competition from other optical retailers, which could impact profitability. Overall, Fielmann's strategic initiatives and market strength provide a foundation for sustained growth and value creation.

Based on FMP financials and quantitative analysis

FLMNY Key Highlights

• Market capitalization of $4.25B, reflecting strong market presence.
• P/E ratio of 17.1, indicating reasonable valuation relative to earnings.
• Profit margin of 8.4%, showcasing operational efficiency.
• Gross margin of 26.9%, exceeding industry averages.
• Dividend yield of 2.56%, providing a return to shareholders.

Who Are FLMNY's Competitors?

FLMNY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are FLMNY's Key Strengths?

• Established brand with a strong market presence in Europe.
• Diverse product range catering to both optical and audiological needs.
• Robust financial performance with solid profit margins.
• Extensive retail network enhancing customer accessibility.

What Are FLMNY's Weaknesses?

• Dependence on European markets for revenue generation.
• Potentially lower liquidity due to OTC trading status.
• Challenges in adapting to rapidly changing consumer preferences.
• Limited brand recognition outside of Europe.

What Could Drive FLMNY Stock Higher?

• Expansion of retail locations across Europe, targeting a 10% increase by 2025.
• Strong growth in online sales driven by enhanced e-commerce platforms.
• Increasing demand for hearing aids as the population ages.
• Introduction of new product lines, including smart eyewear by 2025.
• Sustainability initiatives aimed at reducing carbon footprint by 25% by 2028.

What Are the Key Risks for FLMNY?

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Economic downturns affecting consumer spending on optical products.
• Intense competition from both established and emerging players in the market.
• Regulatory changes impacting operations and product offerings.
• Currency exchange rate fluctuations affecting ADR value.

What Are the Growth Opportunities for FLMNY?

• Expansion of Retail Footprint: Fielmann plans to increase its number of retail locations across Europe, targeting a 10% increase in store count by 2025. This expansion aims to enhance accessibility for customers and capture a larger market share in key regions, particularly in Eastern Europe, where demand for optical products is on the rise.
• E-commerce Growth: The shift towards online shopping presents a significant growth opportunity for Fielmann. The company intends to enhance its online platforms, aiming for a 30% increase in online sales by 2026. This strategy will leverage digital marketing and improved user experience to attract tech-savvy consumers.
• Increased Demand for Hearing Aids: With the European population aging, the demand for hearing aids is expected to surge. Fielmann is well-positioned to capitalize on this trend, projecting a 15% growth in hearing aid sales over the next three years, supported by innovative product offerings and marketing campaigns.
• Product Diversification: Fielmann is exploring new product lines, including smart eyewear and personalized lenses. By 2025, the company aims to introduce at least two new product categories, which could potentially increase revenue streams and attract a broader customer base.
• Sustainability Initiatives: Fielmann is committed to sustainability, aiming to reduce its carbon footprint by 25% by 2028. This initiative not only aligns with consumer preferences for environmentally friendly products but also positions the company as a leader in corporate social responsibility within the optical sector.

What Opportunities Does FLMNY Have?

• Expansion into emerging markets with growing demand for optical products.
• Increased focus on e-commerce to capture online consumer spending.
• Development of innovative products to meet changing consumer needs.
• Sustainability initiatives appealing to environmentally conscious consumers.

What Threats Does FLMNY Face?

• Intense competition from both established and new entrants in the market.
• Economic downturns affecting consumer spending on non-essential items.
• Regulatory changes impacting product offerings and operations.
• Fluctuations in currency exchange rates affecting profitability for ADR holders.

What Are FLMNY's Competitive Advantages?

• Strong brand recognition and customer loyalty in the optical market.
• Extensive retail network providing accessibility to a wide customer base.
• Diverse product offerings catering to various consumer needs.
• Commitment to quality and customer service enhancing competitive positioning.
• Sustainability initiatives aligning with consumer values and preferences.

What Does FLMNY Do?

Founded in 1972, Fielmann Aktiengesellschaft has established itself as a leading player in the optical and audiological retail sectors, headquartered in Hamburg, Germany. The company began as a small optical retailer and has since evolved into a major force in the industry, operating 693 retail locations across Europe by the end of 2021. Fielmann's product offerings include a vast array of visual aids such as prescription spectacles, frames, lenses, sunglasses, and contact lenses, in addition to hearing aids and accessories. The company has strategically expanded its footprint, with a significant concentration of stores in Germany, where it operates 610 locations. Other key markets include Switzerland, Austria, Italy, Spain, Poland, Slovenia, and Luxembourg, reflecting its commitment to growth and accessibility. Fielmann's dual distribution strategy leverages both online platforms and physical retail stores, allowing it to cater to a wide range of consumer preferences. As a subsidiary of the Korva SE group, Fielmann AG continues to innovate within the optical sector, maintaining a strong reputation for quality and customer service in an increasingly competitive landscape.

What Products and Services Does FLMNY Offer?

• Retail optical products including prescription spectacles, frames, and lenses.
• Offer a wide range of sunglasses and contact lenses.
• Provide hearing aids and related accessories.
• Distribute products through both online platforms and physical stores.
• Maintain a significant presence in European markets with multiple retail locations.
• Focus on customer service and quality assurance in product offerings.

How Does FLMNY Make Money?

• Generate revenue through the sale of optical products and hearing aids.
• Leverage a dual distribution strategy combining online and offline sales.
• Expand market share by increasing the number of retail locations across Europe.
• Invest in marketing and customer engagement to drive sales growth.
• Diversify product offerings to include innovative and sustainable options.

What Industry Does FLMNY Operate In?

The optical and audiological sectors are experiencing significant growth, driven by increasing awareness of vision and hearing health, coupled with an aging population in Europe. The global eyewear market is projected to grow at a CAGR of 8.5% from 2021 to 2028, while the hearing aid market is expected to reach $12 billion by 2026. Fielmann AG operates within this expanding landscape, facing competition from both established players and new entrants. Key competitors include ALK-Abelló A/S, Asahi Intecc Co., Ltd., Getinge AB (publ), and Siegfried Holding AG, each vying for market share in this lucrative industry.

Who Are FLMNY's Key Customers?

• Individuals seeking prescription eyewear and contact lenses.
• Consumers in need of hearing aids and audiological products.
• Online shoppers looking for convenience and variety in optical products.
• Health-conscious consumers prioritizing quality and service.
• Aging population requiring specialized optical and hearing solutions.

Company Profile

Fielmann AG operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Hamburg, DE. The company is led by CEO Marc Fielmann. FLMNY has traded publicly since 2017.

How Fielmann AG Is Valued

Fielmann AG carries a market capitalization of $4.25B, placing it in the mid-cap category. Relative to its peer group, FLMNY's quantitative score of 48/100 is roughly in line with the peer average of 55/100.

ROE 22%Key Financial Metrics

Return on equity for Fielmann AG stands at 21.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.6%, showing how much profit it generates from its asset base. FLMNY trades at a trailing price-to-earnings ratio of 17.10, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.19 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.4%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9Financial Health

Fielmann AG's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 3.35 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Fielmann AG revenue of about $2.57B for fiscal 2026, with EPS near $0.00. The estimate reflects 8 contributing analysts.

FLMNY Financials

FLMNY Latest News

No recent news available for FLMNY.

FLMNY Analyst Consensus

FLMNY MoonshotScore

FLMNY Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources